Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma.
about
Design and rationale of FOCUS (PX-171-011): a randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).Combination of cyclophosphamide, etoposide, carboplatin and dexamethasone as a salvage regimen for refractory multiple myeloma patients: a comparison with a historical control group.Treatment of relapsed and refractory myeloma.Metronomic chemotherapy.Frail elderly patients with relapsed-refractory multiple myeloma: efficacy and toxicity profile of the combination of bortezomib, high-dose dexamethasone, and low-dose oral cyclophosphamide.Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma.Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients
P2860
Q31094748-6301D3EF-4A1C-4657-870B-9EA4516BBE26Q33433893-AC85C33A-35FF-4B78-95EB-C77F57A9FCFFQ36331737-AB74487C-2A3F-4CAF-AFD1-E4412ED3CFC4Q37209929-A1DE0613-F688-45B9-93EA-303BCD94CDD2Q38248269-570FF8FB-B0A9-4056-9189-97F3486524B3Q43115837-789B281D-DC91-4AC8-BFAC-122C90350DF3Q44512399-4ADB04F9-57E2-4A24-B39D-821FEB068D23Q58552961-A93A2095-E075-4E2B-AB7D-673ACFB4D266
P2860
Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Continuous low-dose cyclophosp ...... ith advanced multiple myeloma.
@en
Continuous low-dose cyclophosp ...... ith advanced multiple myeloma.
@nl
type
label
Continuous low-dose cyclophosp ...... ith advanced multiple myeloma.
@en
Continuous low-dose cyclophosp ...... ith advanced multiple myeloma.
@nl
prefLabel
Continuous low-dose cyclophosp ...... ith advanced multiple myeloma.
@en
Continuous low-dose cyclophosp ...... ith advanced multiple myeloma.
@nl
P2093
P1476
Continuous low-dose cyclophosp ...... ith advanced multiple myeloma.
@en
P2093
Hagenbeek A
Lokhorst HM
de Weerdt O
van de Donk NW
P356
10.1016/S0300-2977(01)00140-1
P577
2001-08-01T00:00:00Z